As FDA continues to assess its response to last year's H1N1 pandemic, a top agency official said this week that FDA should examine its approach to foster the development of adaptable technologies. The position is mirrored in a new HHS medical countermeasures enterprise report, which recommends that FDA consider use of new, multi-use manufacturing facilities; develop at least three flu vaccine candidates that don't rely on virus grown in eggs or cells; and lead an HHS-wide effort to review new regulatory and legal approaches for adding products to the stockpile.
Forgot password?
Sign up today and your first download is free.
REGISTER
Emergency Response
July 30, 2010 |
Daily News
The Senate is slated to hold a cloture vote Monday on a substitute amendment (SA 4567) to the House Federal Aviation Administration reauthorization bill (HR 1586) that includes funding for a long-sought extension of enhanced Medicaid payments and tweaks the calculation of how drugs are paid for under Medicaid. Sources have said that it is imperative to secure the Medicaid safety net system in order to ensure the insurance expansions mandated by health reform are achievable.
Pages
© 2002-2021. Inside Washington Publishers